查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679208

聚合物奈米粒子市場至2030年的預測：按類型、聚合物類型、應用、最終用戶和地區的全球分析

Polymeric Nanoparticles Market Forecasts to 2030 - Global Analysis By Type (Nanocapsules and Nanospheres), Polymer Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2024年全球聚合物奈米粒子市值為 7.8425億美元，預計到2030年將達到 15.7592億美元，預測期內的年複合成長率為 12.5%。

聚合物奈米粒子是生物相容性、生物分解性的微小粒子，尺寸在 10 到 1000 奈米之間，由天然或合成聚合物組成。可作為藥物、基因和生物分子的載體，增強穩定性、控制釋放和標靶遞送。其應用涵蓋醫學、製藥和生物技術領域，可提高藥物溶解度、生物有效性和治療效果。

美國國家醫學圖書館2023年的研究報告顯示，奈米技術有潛力有效治療50%以上的心血管疾病。

靶向藥物傳輸需求不斷成長

聚合物奈米粒子可實現控制和特異性的藥物釋放，使其成為治療癌症、心血管和神經系統疾病等慢性疾病的理想選擇。由於它們具有防止藥物分解和提高生物有效性的能力，因此在製藥領域的應用越來越廣泛。此外，疾病盛行率的上升和奈米技術研發的不斷增加進一步推動了基於聚合物奈米粒子的藥物傳輸系統的開發和商業化。

潛在的毒性問題

聚合物奈米粒子因其尺寸小、表面反應性強、在組織中生物累積的可能性而具有潛在的毒性問題，導致意想不到的健康和環境風險。長時間接觸可能會導致細胞損傷、發炎和免疫系統反應。更嚴格的測試要求和謹慎的消費者看法將進一步推遲商業化，增加成本並降低投資者信心，阻礙整體市場成長。

增加奈米醫學的投資

政府、製藥公司和研究機構的資助促進了用於靶向藥物傳輸、基因治療和癌症治療的新型聚合物奈米粒子製劑的開發。這些投資支持臨床試驗、監管部門核准和大規模生產，使聚合物奈米粒子更容易用於醫療應用。因此，擴大奈米醫學資金的投入直接推動了聚合物奈米粒子的需求和應用。

複雜的組合和擴充性的挑戰

由於精確的配方要求、複雜的聚合物選擇以及對尺寸、穩定性和藥物負載效率的控制的需求，聚合物奈米粒子麵臨著複雜的合成和可擴展性的挑戰。乳液聚合和奈米沉澱等先進技術需要嚴格的製程控制，這使得大規模生產變得困難且成本高昂。這些挑戰阻礙了大規模生產、推高了成本並限制了採用，尤其是在新興市場。

COVID-19 的影響：

COVID-19 疫情對聚合物奈米粒子市場產生了重大影響，既有正面影響，也有負面影響。全球供應鏈中斷最初阻礙了生產和原料的供應。然而，對基於奈米載體的藥物輸送系統和疫苗開發的需求不斷增加，推動了市場的成長。聚合物奈米粒子在mRNA疫苗和標靶治療的遞送中發揮了重要作用。疫情過後，由於生物醫學科學的進步和奈米技術的持續投資，市場繼續擴大。

基因治療領域預計將成為預測期內最大的市場

預計在預測期內，基因治療領域將佔據市場佔有率。聚合物奈米粒子能夠安全有效地傳遞遺傳物質，在基因治療中扮演重要角色。這些生物分解性和生物相容性的載體可保護核酸（DNA、RNA）免於分解、促進細胞吸收並實現控制釋放。與病毒載體相比，PNP 可以抑制免疫反應並提高基因轉移效率。

預計預測期內化妝品和個人護理領域將以最高的年複合成長率成長。

由於產品功效、穩定性和皮膚滲透性的提高，預計化妝品和個人護理領域將在預測期內實現最高成長率。 PNPs 用於護膚、頭髮護理、防曬油等，有助於控制釋放、維持其有效性並提高生物有效性。 PNP 可保護維生素、抗氧化劑和UV防曬敏感活性成分免於劣化。由於體積小，PNP 可皮膚深層吸收，增強其保濕和抗衰老效果。

佔比最大的地區：

在預測期內，由於醫藥、藥物輸送、化妝品和食品包裝的需求不斷增加，預計亞太地區將佔據最大的市場佔有率。中國、印度和日本等國家憑藉著不斷擴大的醫療保健基礎設施、不斷增加的研發投入和技術進步，在市場中佔據領先地位。此外，政府對奈米技術研究和永續包裝解決方案的支持也促進了市場擴張。

年複合成長率最高的地區：

預計北美地區在預測期內將呈現最高的年複合成長率。這是由於奈米技術的進步、藥物傳輸應用的不斷增加以及醫療保健、電子和食品包裝行業的需求不斷成長。美國以強大的研發投入和醫藥創新引領市場。政府資助以及生物技術公司和研究機構之間的合作進一步推動了該地區的發展。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之1：

  • 公司簡介
    • 對其他市場公司（最多3家公司）進行全面分析
    • 主要企業的SWOT 分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 促進因素
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭敵對

第5章 全球聚合物奈米粒子市場類型

  • 奈米膠囊
  • 奈米球

第6章 全球聚合物奈米粒子市場（依聚合物類型）

  • 天然聚合物
    • 幾丁聚醣
    • 纖維素
    • 明膠
    • 海藻酸鹽
  • 合成聚合物
    • 聚乳酸（PLA）
    • 聚乳酸-乙醇酸共聚物（PLGA）
    • 聚己內酯（PCL）
    • 聚乙二醇（PEG）
    • 聚丙烯醯胺

第7章 全球聚合物奈米粒子市場（依應用）

  • 藥物輸送
  • 癌症治療
  • 疫苗遞送
  • 診斷和影像
  • 組織工程與再生醫學
  • 基因治療
  • 其他用途

第8章 全球聚合物奈米粒子市場（依最終用戶）

  • 製藥和生物技術
  • 化妝品和個人護理
  • 食品和飲料
  • 農業及農藥
  • 其他最終用戶

第9章 全球聚合物奈米粒子市場（依地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Arkema
  • BASF SE
  • Aphios Corporation
  • Cabot Corporation
  • CD Bioparticles
  • Liquidia Technologies
  • Hybrid Plastics Inc.
  • Nanorh
  • Precision NanoSystems Inc.
  • Sigma-Aldrich
  • Bruker
  • Nanoform
  • Fortis Life Sciences
  • Nanotherapeutics Inc.
  • Spectradyne
  • Revalesio Corporation
  • Cerulean Pharma Inc.
  • Alnylam Pharmaceuticals
Product Code: SMRC28791

According to Stratistics MRC, the Global Polymeric Nanoparticles Market is accounted for $784.25 million in 2024 and is expected to reach $1575.92 million by 2030 growing at a CAGR of 12.5% during the forecast period. Polymeric nanoparticles are tiny, biocompatible, and biodegradable particles ranging from 10 to 1000 nm in size, composed of natural or synthetic polymers. They serve as carriers for drugs, genes, or biomolecules, enhancing stability, controlled release, and targeted delivery. Their applications span medicine, pharmaceuticals, and biotechnology, improving drug solubility, bioavailability, and therapeutic efficiency.

According to a study report by the National Library of Medicines in 2023 revealed that nanotechnology may efficiently treat over 50% of CVDs.

Market Dynamics:

Driver:

Growing demand for targeted drug delivery

Polymeric nanoparticles enable controlled and site-specific drug release, making them ideal for treating chronic diseases like cancer, cardiovascular disorders, and neurological conditions. Their ability to protect drugs from degradation and enhance bioavailability increases their adoption in pharmaceuticals. Additionally, the rising prevalence of diseases and increasing R&D in nanotechnology further drive the development and commercialization of polymeric nanoparticle-based drug delivery systems.

Restraint:

Potential toxicity issues

Polymeric nanoparticles pose potential toxicity issues due to their small size, surface reactivity, and possible bioaccumulation in tissues, leading to unforeseen health and environmental risks. Their prolonged exposure may cause cellular damage, inflammation, or immune system responses. Stricter testing requirements and cautious consumer perception further delay commercialization, increasing costs and reducing investor confidence, thereby hampering overall market growth.

Opportunity:

Increasing investments in nanomedicine

Funding from governments, pharmaceutical companies, and research institutions enables the development of novel polymeric nanoparticle formulations for targeted drug delivery, gene therapy, and cancer treatment. These investments support clinical trials, regulatory approvals, and large-scale production, making polymeric nanoparticles more accessible for medical applications. As a result, expanding nanomedicine funding directly fuels the demand and adoption of polymeric nanoparticles.

Threat:

Complex synthesis & scalability challenges

Polymeric nanoparticles face complex synthesis and scalability challenges due to precise formulation requirements, intricate polymer selection, and the need for controlled size, stability, and drug-loading efficiency. Advanced techniques like emulsion polymerization and nanoprecipitation require strict process control, making large-scale production difficult and expensive. These challenges hinder mass production, increase costs, and limit widespread adoption, especially in developing markets.

Covid-19 Impact:

The covid-19 pandemic significantly impacted the polymeric nanoparticles market, both positively and negatively. Disruptions in the global supply chain initially slowed production and raw material availability. However, increased demand for nanocarrier-based drug delivery systems and vaccine development boosted market growth. Polymeric nanoparticles played a crucial role in mRNA vaccine delivery and targeted therapeutics. Post-pandemic, the market continues to expand, driven by biomedical advancements and sustained investment in nanotechnology.

The gene therapy segment is expected to be the largest during the forecast period

The gene therapy segment is expected to account for the largest market share during the forecast period. Polymeric nanoparticles play a crucial role in gene therapy by enabling safe and efficient delivery of genetic material. These biodegradable and biocompatible carriers protect nucleic acids (DNA, RNA) from degradation, enhance cellular uptake, and enable controlled release. PNPs reduce immune responses and improve gene transfection efficiency compared to viral vectors.

The cosmetics & personal care segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetics & personal care segment is predicted to witness the highest growth rate, owing to its enhanced product efficacy, stability, and skin penetration. They are used in skincare, haircare, and sunscreens for controlled ingredient release, prolonged effects, and improved bioavailability. PNPs protect sensitive active ingredients like vitamins, antioxidants, and UV filters from degradation. Their small size enables deeper skin absorption, enhancing hydration and anti-aging benefits.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing demand in pharmaceuticals, drug delivery, cosmetics, and food packaging. Countries like China, India, and Japan are leading the market, driven by expanding healthcare infrastructure, rising R&D investments, and technological advancements. Additionally, government support for nanotechnology research and sustainable packaging solutions contributes to market expansion.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by advancements in nanotechnology, increasing applications in drug delivery, and rising demand in healthcare, electronics, and food packaging industries. The U.S. leads the market with strong R&D investments and pharmaceutical innovations. Government funding and collaborations between biotech firms and research institutions further fuels the region's growth.

Key players in the market

Some of the key players in Polymeric Nanoparticles market include Arkema, BASF SE, Aphios Corporation, Cabot Corporation, CD Bioparticles, Liquidia Technologies, Hybrid Plastics Inc., Nanorh, Precision NanoSystems Inc., Sigma-Aldrich, Bruker, Nanoform, Fortis Life Sciences, Nanotherapeutics Inc., Spectradyne, Revalesio Corporation, Cerulean Pharma Inc. and Alnylam Pharmaceuticals.

Key Developments:

In December 2024, BASF inaugurated its new Catalyst Development and Solids Processing Center in Ludwigshafen, Germany. This state-of-the-art research facility serves as a hub for pilot-scale synthesis of chemical catalysts and the development of new solids processing technologies. The center aims to accelerate the transition from laboratory-scale innovations to production-ready solutions, providing global customers with faster access to advanced technologies.

In May 2024, Arkema introduced the peroxide-cured resin compositions that maintain extended open times at ambient temperatures while achieving rapid cure times when exposed to elevated temperatures. This development signifies Arkema's commitment to advancing materials science, offering solutions that improve both the performance and processing efficiency of resin-based composite materials.

Types Covered:

  • Nanocapsules
  • Nanospheres

Polymer Types Covered:

  • Natural Polymers
  • Synthetic Polymers

Applications Covered:

  • Drug Delivery
  • Cancer Therapy
  • Vaccine Delivery
  • Diagnostics & Imaging
  • Tissue Engineering & Regenerative Medicine
  • Gene Therapy
  • Other Applications

End Users Covered:

  • Pharmaceuticals & Biotechnology
  • Cosmetics & Personal Care
  • Food & Beverages
  • Agriculture & Pesticides
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Polymeric Nanoparticles Market, By Type

  • 5.1 Introduction
  • 5.2 Nanocapsules
  • 5.3 Nanospheres

6 Global Polymeric Nanoparticles Market, By Polymer Type

  • 6.1 Introduction
  • 6.2 Natural Polymers
    • 6.2.1 Chitosan
    • 6.2.2 Cellulose
    • 6.2.3 Gelatin
    • 6.2.4 Alginate
  • 6.3 Synthetic Polymers
    • 6.3.1 Polylactic Acid (PLA)
    • 6.3.2 Poly(lactic-co-glycolic acid) (PLGA)
    • 6.3.3 Polycaprolactone (PCL)
    • 6.3.4 Polyethylene Glycol (PEG)
    • 6.3.5 Polyacrylamide

7 Global Polymeric Nanoparticles Market, By Application

  • 7.1 Introduction
  • 7.2 Drug Delivery
  • 7.3 Cancer Therapy
  • 7.4 Vaccine Delivery
  • 7.5 Diagnostics & Imaging
  • 7.6 Tissue Engineering & Regenerative Medicine
  • 7.7 Gene Therapy
  • 7.8 Other Applications

8 Global Polymeric Nanoparticles Market, By End User

  • 8.1 Introduction
  • 8.2 Pharmaceuticals & Biotechnology
  • 8.3 Cosmetics & Personal Care
  • 8.4 Food & Beverages
  • 8.5 Agriculture & Pesticides
  • 8.6 Other End Users

9 Global Polymeric Nanoparticles Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.9 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.9 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.9 Middle East & Africa
    • 9.9.1 Saudi Arabia
    • 9.9.2 UAE
    • 9.9.3 Qatar
    • 9.9.4 South Africa
    • 9.9.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Arkema
  • 11.2 BASF SE
  • 11.3 Aphios Corporation
  • 11.4 Cabot Corporation
  • 11.5 CD Bioparticles
  • 11.6 Liquidia Technologies
  • 11.7 Hybrid Plastics Inc.
  • 11.8 Nanorh
  • 11.9 Precision NanoSystems Inc.
  • 11.10 Sigma-Aldrich
  • 11.11 Bruker
  • 11.12 Nanoform
  • 11.13 Fortis Life Sciences
  • 11.14 Nanotherapeutics Inc.
  • 11.15 Spectradyne
  • 11.16 Revalesio Corporation
  • 11.17 Cerulean Pharma Inc.
  • 11.18 Alnylam Pharmaceuticals

List of Tables

  • Table 1 Global Polymeric Nanoparticles Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Polymeric Nanoparticles Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Polymeric Nanoparticles Market Outlook, By Nanocapsules (2022-2030) ($MN)
  • Table 4 Global Polymeric Nanoparticles Market Outlook, By Nanospheres (2022-2030) ($MN)
  • Table 5 Global Polymeric Nanoparticles Market Outlook, By Polymer Type (2022-2030) ($MN)
  • Table 6 Global Polymeric Nanoparticles Market Outlook, By Natural Polymers (2022-2030) ($MN)
  • Table 7 Global Polymeric Nanoparticles Market Outlook, By Chitosan (2022-2030) ($MN)
  • Table 8 Global Polymeric Nanoparticles Market Outlook, By Cellulose (2022-2030) ($MN)
  • Table 9 Global Polymeric Nanoparticles Market Outlook, By Gelatin (2022-2030) ($MN)
  • Table 10 Global Polymeric Nanoparticles Market Outlook, By Alginate (2022-2030) ($MN)
  • Table 11 Global Polymeric Nanoparticles Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 12 Global Polymeric Nanoparticles Market Outlook, By Polylactic Acid (PLA) (2022-2030) ($MN)
  • Table 13 Global Polymeric Nanoparticles Market Outlook, By Poly(lactic-co-glycolic acid) (PLGA) (2022-2030) ($MN)
  • Table 14 Global Polymeric Nanoparticles Market Outlook, By Polycaprolactone (PCL) (2022-2030) ($MN)
  • Table 15 Global Polymeric Nanoparticles Market Outlook, By Polyethylene Glycol (PEG) (2022-2030) ($MN)
  • Table 16 Global Polymeric Nanoparticles Market Outlook, By Polyacrylamide (2022-2030) ($MN)
  • Table 17 Global Polymeric Nanoparticles Market Outlook, By Application (2022-2030) ($MN)
  • Table 18 Global Polymeric Nanoparticles Market Outlook, By Drug Delivery (2022-2030) ($MN)
  • Table 19 Global Polymeric Nanoparticles Market Outlook, By Cancer Therapy (2022-2030) ($MN)
  • Table 20 Global Polymeric Nanoparticles Market Outlook, By Vaccine Delivery (2022-2030) ($MN)
  • Table 21 Global Polymeric Nanoparticles Market Outlook, By Diagnostics & Imaging (2022-2030) ($MN)
  • Table 22 Global Polymeric Nanoparticles Market Outlook, By Tissue Engineering & Regenerative Medicine (2022-2030) ($MN)
  • Table 23 Global Polymeric Nanoparticles Market Outlook, By Gene Therapy (2022-2030) ($MN)
  • Table 24 Global Polymeric Nanoparticles Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 25 Global Polymeric Nanoparticles Market Outlook, By End User (2022-2030) ($MN)
  • Table 26 Global Polymeric Nanoparticles Market Outlook, By Pharmaceuticals & Biotechnology (2022-2030) ($MN)
  • Table 27 Global Polymeric Nanoparticles Market Outlook, By Cosmetics & Personal Care (2022-2030) ($MN)
  • Table 28 Global Polymeric Nanoparticles Market Outlook, By Food & Beverages (2022-2030) ($MN)
  • Table 29 Global Polymeric Nanoparticles Market Outlook, By Agriculture & Pesticides (2022-2030) ($MN)
  • Table 30 Global Polymeric Nanoparticles Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.